Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Executive Branch
White House Office of National Drug Control Policy (ONDCP) Releases Opioid…
The White House Office of National Drug Control Policy (“ONDCP”) recently released a publication outlining strategies intended to…
OMB Dissatisfied with Quality Payment Program and Innovation Center
In early June 2018, Joseph Grogan, associate director for health programs for the Office of Management and Budget (OMB), spoke out…
President Signs Right to Try – Keep on Trying
Yesterday, May 30, 2018, United States President Donald Trump signed the somewhat controversial “Right to Try” Act, which was…
President Trump Gives Remarks on Lowering Drug Prices
“We will see those prices go down, it will be a beautiful thing to watch.” President Donald J. Trump
In less than twenty-five…
The End of Guidance Documents or Simply a Reminder of Well-Established…
As discussed in several news outlets, the Trump Administration recently announced that it would begin to enforce long-standing…
White House White Paper on Pharma Pricing Released
In February 2018, the White House Council of Economic Advisers released a white paper, “Reforming Biopharmaceutical Pricing at…
Trump Administration Releases Budget Proposal Calls for Changes to Open…
The Trump Administration recently released its fiscal year (FY) 2019 budget proposal, including extensive health policy…
State of the Union De-Briefing
President Donald Trump gave his second State of the Union address this week, and while reactions to his speech were mixed, he…
Trump Nominates Alex Azar to Head HHS
A few weeks ago, President Donald Trump nominated Alex Azar to lead the Department of Health and Human Services (HHS), following…
President Trump Declares Opioid Crisis a National Emergency
Working off of the recent recommendations in the interim report issued by the President’s Commission on Combating Drug Addiction…